Evidence map›Paper›PMID 38154232›Full record

ArticleInternational journal of surgery case reports2024

Choosing Juvéderm Volux™ to chin augmentation: Case report and flowchart for clinical evaluation.

Alessandra Kuhn Dall'Magro, Letícia Copatti Dogenski, James Olding, Eduardo Dall'Magro, Felipe Gomes Dallepiane, João Paulo De Carli

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandra Kuhn Dall'MagroUniversity of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil.
Letícia Copatti DogenskiUniversity of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil.
James OldingSpecialist Registrar Oral & Maxillofacial Surgery, NHSKing's College London, London, England, United Kingdom.
Eduardo Dall'MagroUniversity of Campinas, Piracicaba, São Paulo, Brazil.
Felipe Gomes DallepianeFederal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
João Paulo De CarliUniversity of Passo Fundo, Passo Fundo, Rio Grande do Sul, Brazil. Electronic address: joaodecarli@upf.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe development of filler biomaterials with high hyaluronic acid concentrations, cohesiveness, and elastic modulus has become an option for chin augmentation, as the balance of these rheological properties promotes high lifting capacity, providing minimally invasive perceptible improvements in patient appearance. PRESENTATION OF CASE: The present study reviewed clinical and anatomical aspects of patients referred for chin augmentation and created a flowchart to assertively diagnose patients with an indication of Juvéderm® Volux™ for defining the lower third of the face. DISCUSSION: The chin is vital for facial proportions and attractiveness perception. Its relevance to facial appearance is noticed the most when chin size is less than ideal, making other facial areas seem larger or smaller. The adjacent soft tissues of the neck and jaw appear prematurely aged when chin projection or width is inadequate. Hyaluronic acid-based fillers have a confirmed history of safe and effective use for treating facial volume loss or deficiency.

conclusionJuvéderm® Volux™ is a safe, effective, and long-lasting alternative for restoring and creating facial volume and sculpting, shaping, and contouring the chin and jaw.

Indexed as

Case reportChin augmentationHyaluronic acidJuvéderm® Volux™VYC-25 L

Identifiers

PMID38154232
PMCPMC10800642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.